Skip to search.
 TSX Up 0.06% TSX Ventures Down 1.39%

OncoGenex Pharmaceuticals, Inc. (OGXI)

-NasdaqCM
2.21 Down 0.02(0.67%) 3:46PM EDT - Nasdaq Real Time Price
Add to Portfolio
Prev Close:2.23
Open:2.20
Bid:2.23 x 100
Ask:2.24 x 400
1y Target Est:5.75
Beta:0.93
Next Earnings Date: 3-Aug-15OGXI Earnings announcement
Day's Range:2.10 - 2.25
52wk Range:1.74 - 3.57
Volume:143,468
Avg Vol (3m):344,549
Market Cap:52.52M
P/E (ttm):N/A
EPS (ttm):-1.10
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
OGXIDown 0.67%52.52M
BMYUp 1.01%113.65B
CELGUp 0.31%94.53B
PFEUp 1.52%207.85B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):3.15
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.97
Quarterly EPS Est (Jun-15) :0.34
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

OncoGenex Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies that address treatment resistance in cancer patients. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback